Blázquez-Medela AM et al. |
Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. |
2012 |
Eur. J. Clin. Invest. |
pmid:22050177
|
Heymann MF et al. |
Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds. |
2012 |
Cytokine |
pmid:22402034
|
Terpos E et al. |
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. |
2011 Nov-Dec |
Clin. Exp. Rheumatol. |
pmid:22032557
|
Arikan F et al. |
C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. |
2011 Mar-Apr |
Int J Oral Maxillofac Implants |
pmid:21483881
|
Crespi R et al. |
Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. |
2011 Jul-Aug |
Int J Oral Maxillofac Implants |
pmid:21841997
|
Franke S et al. |
Advanced glycation end products affect growth and function of osteoblasts. |
2011 Jul-Aug |
Clin. Exp. Rheumatol. |
pmid:21906430
|
Rezg R et al. |
Inhibitors of vascular calcification as potential therapeutic targets. |
2011 Jul-Aug |
J. Nephrol. |
pmid:21688249
|
Reyes-GarcÃa R et al. |
[Cardiovascular disease and bone metabolism]. |
2011 Aug-Sep |
Endocrinol Nutr |
pmid:21775224
|
Ostrowska Z et al. |
Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. |
2011 |
Postepy Hig Med Dosw (Online) |
pmid:22100799
|
Kurabayashi M |
[Bone and calcium update; diagnosis and therapy of bone metabolism disease update. Calcification of atherosclerotic plaques: mechanism and clinical significance]. |
2011 |
Clin Calcium |
pmid:22133823
|
Tsioufis C et al. |
Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction. |
2011 |
Expert Opin. Ther. Targets |
pmid:22136618
|
Zhou J et al. |
Expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in root resorption induced by heavy force in rats. |
2011 |
J Orofac Orthop |
pmid:22138776
|
Grzibovskis M et al. |
Specific signaling molecule expressions in the interradicular septum in different age groups. |
2011 |
Stomatologija |
pmid:22071415
|
Wang Y et al. |
Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats. |
2011 |
J Orthop Surg Res |
pmid:21752290
|
Plasilova M et al. |
Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). |
2011 |
PLoS ONE |
pmid:21738662
|
Ren G et al. |
Simultaneous administration of fluoride and selenite regulates proliferation and apoptosis in murine osteoblast-like MC3T3-E1 cells by altering osteoprotegerin. |
2011 |
Biol Trace Elem Res |
pmid:21739163
|
Sylvester FA et al. |
Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis. |
2011 |
Inflamm. Bowel Dis. |
pmid:21744427
|
Weinstein RS et al. |
Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. |
2011 |
Endocrinology |
pmid:21771887
|
Lee JH et al. |
Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis. |
2011 |
BMB Rep |
pmid:21777519
|
Baldi D et al. |
Dental implants osteogenic properties evaluated by cDNA microarrays. |
2011 |
Implant Dent |
pmid:21778890
|
Kwan JS et al. |
Heritability of serum osteoprotegerin. |
2011 |
Ann. Hum. Genet. |
pmid:21762114
|
Ibrahim T et al. |
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. |
2011 |
Clin. Breast Cancer |
pmid:21764390
|
Nakashima A et al. |
Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients. |
2011 |
Osteoporos Int |
pmid:20812007
|
Chen WF et al. |
Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. |
2011 |
Br. J. Nutr. |
pmid:20815976
|
Zinonos I et al. |
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. |
2011 |
J. Bone Miner. Res. |
pmid:20818644
|
Loncar G et al. |
Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. |
2011 |
J. Endocrinol. Invest. |
pmid:20820131
|
Tao H et al. |
P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. |
2011 |
PLoS ONE |
pmid:21886782
|
Lawrie A et al. |
Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. |
2011 |
Am. J. Pathol. |
pmid:21835155
|
Poulsen MK et al. |
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. |
2011 |
Cardiovasc Diabetol |
pmid:21838881
|
Markatseli AE et al. |
Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women. |
2011 |
Maturitas |
pmid:21840657
|
Kauther MD et al. |
Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis. |
2011 |
BMC Musculoskelet Disord |
pmid:21843355
|
Gradosova I et al. |
The role of atorvastatin in bone metabolism in male albino Wistar rats. |
2011 |
Pharmazie |
pmid:21901984
|
Straface G et al. |
Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. |
2011 |
Stroke |
pmid:21903966
|
Vitoratos N et al. |
Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women. |
2011 |
Eur. J. Obstet. Gynecol. Reprod. Biol. |
pmid:21074311
|
Belibasakis GN et al. |
Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. |
2011 |
Microb. Pathog. |
pmid:21075196
|
Tripathi A et al. |
Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns. |
2011 |
J Prosthodont |
pmid:21883630
|
Wattanaroonwong N et al. |
Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts. |
2011 |
Arch. Oral Biol. |
pmid:21035111
|
D'Amelio P et al. |
Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. |
2011 |
Osteoporos Int |
pmid:21116815
|
Giner M et al. |
Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. |
2011 |
Eur. J. Pharmacol. |
pmid:21050847
|
Hie M and Tsukamoto I |
Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. |
2011 |
J. Nutr. Biochem. |
pmid:20444587
|
Belibasakis GN et al. |
Porphyromonas gingivalis induces RANKL in T-cells. |
2011 |
Inflammation |
pmid:20446027
|
Dzida G |
[Decalcified bones, calcified heart?]. |
2011 |
Kardiol Pol |
pmid:21678295
|
Yang Q et al. |
Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions. |
2011 |
Clin Cardiol |
pmid:21678453
|
Toffoli B et al. |
Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. |
2011 |
Atherosclerosis |
pmid:21679949
|
de Moraes M et al. |
Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. |
2011 |
Arch. Oral Biol. |
pmid:21683340
|
Ndip A et al. |
The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. |
2011 |
Diabetes |
pmid:21659498
|
Gulseren A et al. |
Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. |
2011 |
Panminerva Med |
pmid:21659972
|
Corallini F et al. |
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. |
2011 |
J. Cell. Physiol. |
pmid:21660951
|
Costa-Rodrigues J and Fernandes MH |
Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts. |
2011 |
Cell Prolif. |
pmid:21535267
|
Lee YS and Choi EM |
Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. |
2011 |
Cell. Immunol. |
pmid:21683946
|
Schoppet M et al. |
Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21371424
|
Pobeha P et al. |
Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. |
2011 |
Bone |
pmid:21376149
|
Cao H et al. |
Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. |
2011 |
Circ. J. |
pmid:22001292
|
Scialla JJ et al. |
Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. |
2011 |
Clin J Am Soc Nephrol |
pmid:21940840
|
Sfiridaki K et al. |
Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatment. |
2011 |
Mediators Inflamm. |
pmid:21941412
|
Bao L et al. |
Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. |
2011 |
Chem. Biol. Interact. |
pmid:21945525
|
Zhou XW et al. |
[Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:21945761
|
Carmona-Fernandes D et al. |
Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients. |
2011 |
Arthritis Res. Ther. |
pmid:22027240
|
Wang Y et al. |
[Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:22027773
|
Wang JZ et al. |
[Effect of Epimedium extract on osteoprotegerin and RANKL mRNA expressions in glucocorticoid-induced femoral head necrosis in rats]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:22027774
|
Ferrari-Lacraz S and Ferrari S |
Do RANKL inhibitors (denosumab) affect inflammation and immunity? |
2011 |
Osteoporos Int |
pmid:20571772
|
Goto H et al. |
Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. |
2011 |
Biomed. Res. |
pmid:21383509
|
Belibasakis GN et al. |
The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants. |
2011 |
Cytokine |
pmid:21474331
|
Siomou E et al. |
Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. |
2011 |
Pediatr. Nephrol. |
pmid:21479768
|
Sexton WM et al. |
Salivary biomarkers of periodontal disease in response to treatment. |
2011 |
J. Clin. Periodontol. |
pmid:21480939
|
Cordeiro MM et al. |
Primary teeth show less protecting factors against root resorption. |
2011 |
Int J Paediatr Dent |
pmid:21481035
|
Kaneuji T et al. |
Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21459078
|
Luvizuto ER et al. |
Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats. |
2011 |
Arch. Oral Biol. |
pmid:21536255
|
Hall J et al. |
A controlled clinical exploratory study on genetic markers for peri-implantitis. |
2011 |
Eur J Oral Implantol |
pmid:22282733
|
Xu ML et al. |
[An update for the research progress of osteoprotegerin on coronary artery disease]. |
2011 |
Zhonghua Xin Xue Guan Bing Za Zhi |
pmid:22321243
|
Aspenberg P et al. |
Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. |
2011 |
Bone |
pmid:20858557
|
Kurnatowska I et al. |
Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients. |
2011 |
Nephron Clin Pract |
pmid:20861651
|
de Souza Faloni AP et al. |
Jaw and long bone marrows have a different osteoclastogenic potential. |
2011 |
Calcif. Tissue Int. |
pmid:20862464
|
Park JS et al. |
Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. |
2011 |
Eur. J. Endocrinol. |
pmid:20961967
|
Karosi T et al. |
Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. |
2011 |
Eur Arch Otorhinolaryngol |
pmid:20963600
|
Tsukamoto S et al. |
Clinical significance of osteoprotegerin expression in human colorectal cancer. |
2011 |
Clin. Cancer Res. |
pmid:21270110
|
Monnouchi S et al. |
The roles of angiotensin II in stretched periodontal ligament cells. |
2011 |
J. Dent. Res. |
pmid:21270461
|
Chang YH et al. |
Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. |
2011 |
Metab. Clin. Exp. |
pmid:21251686
|
Benslimane-Ahmim Z et al. |
Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. |
2011 |
J. Thromb. Haemost. |
pmid:21255246
|
WaluÅ›-Miarka M et al. |
Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients. |
2011 |
Int. J. Cardiol. |
pmid:21255853
|
Saito CT et al. |
Effect of low-level laser therapy on the healing process after tooth replantation: a histomorphometrical and immunohistochemical analysis. |
2011 |
Dent Traumatol |
pmid:21244626
|
Erkol A et al. |
Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. |
2011 |
Am. J. Cardiol. |
pmid:21247537
|
Sobue T et al. |
Murine TMJ loading causes increased proliferation and chondrocyte maturation. |
2011 |
J. Dent. Res. |
pmid:21248355
|
Ribeiro FV et al. |
Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. |
2011 |
J. Periodontol. |
pmid:21284550
|
Piedra M et al. |
"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". |
2011 |
BMC Med. Genet. |
pmid:22185226
|
Kawaguchi H |
[Approach for therapeutic targets of osteoarthritis]. |
2011 |
Nippon Yakurigaku Zasshi |
pmid:21747205
|
Hou WW et al. |
Involvement of Wnt activation in the micromechanical vibration-enhanced osteogenic response of osteoblasts. |
2011 |
J Orthop Sci |
pmid:21833614
|
Nahidi L et al. |
Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. |
2011 |
Inflamm. Bowel Dis. |
pmid:20848544
|
Watkins M et al. |
Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. |
2011 |
Mol. Biol. Cell |
pmid:21346198
|
Confavreux CB |
Bone: from a reservoir of minerals to a regulator of energy metabolism. |
2011 |
Kidney Int. Suppl. |
pmid:21346725
|
Caetano-Lopes J et al. |
Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. |
2011 |
PLoS ONE |
pmid:21347301
|
Assmann G et al. |
Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study. |
2011 |
J. Dermatol. |
pmid:21352301
|
Audo R et al. |
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis. |
2011 |
Arthritis Rheum. |
pmid:21305500
|
Alexander KA et al. |
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. |
2011 |
J. Bone Miner. Res. |
pmid:21305607
|
Lau CP et al. |
Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone. |
2011 |
J. Orthop. Res. |
pmid:20886653
|
Jabbar S et al. |
Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. |
2011 |
J. Clin. Pathol. |
pmid:21307155
|
Maïmoun L et al. |
In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. |
2011 |
Osteoporos Int |
pmid:21359671
|
Ignatius A et al. |
Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β. |
2011 |
J. Cell. Biochem. |
pmid:21598302
|
Sun CX et al. |
[Patterns of osteoprotegerin or nuclear factor kappa B ligand gene expression in the treatment of bone defect with bone marrow stem cell transplantation and low-frequency vibration]. |
2011 |
Zhonghua Yi Xue Za Zhi |
pmid:21600122
|
Liu ZF et al. |
[Effect of ultrasound on osteoprotegerin and receptor activator nuclear factor kappaB ligand expression during root resorption in rats]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:21602131
|